Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 7 of 7 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Combination Product: mavrilimumab | 1件: Mavrilimumab Mavrilimumab (Mavrilimumab) | 1件: Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬1. Combination Product: mavrilimumab
| 1件: CSF2RA CSF2RA 💬1. Combination Product: mavrilimumab
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ... | 1件: 41 41 💬1. Combination Product: mavrilimumab
| ||||||||||||||
| 2 | MAVRILIMUMAB | 1件: Mavrilimumab Mavrilimumab (Mavrilimumab) | 1件: Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬2. MAVRILIMUMAB
| 1件: CSF2RA CSF2RA 💬2. MAVRILIMUMAB
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ... | 2件: 41 41, 46 💬
| ||||||||||||||
| 3 | Mavrilimumab 10 mg | 1件: Mavrilimumab Mavrilimumab (Mavrilimumab) | 1件: Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬3. Mavrilimumab 10 mg
| 1件: CSF2RA CSF2RA 💬3. Mavrilimumab 10 mg
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ... | 1件: 46 46 💬3. Mavrilimumab 10 mg
| ||||||||||||||
| 4 | Mavrilimumab 100 mg | 1件: Mavrilimumab Mavrilimumab (Mavrilimumab) | 1件: Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬4. Mavrilimumab 100 mg
| 1件: CSF2RA CSF2RA 💬4. Mavrilimumab 100 mg
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ... | 1件: 46 46 💬4. Mavrilimumab 100 mg
| ||||||||||||||
| 5 | Mavrilimumab 150 mg | 1件: Mavrilimumab Mavrilimumab (Mavrilimumab) | 1件: Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬5. Mavrilimumab 150 mg
| 1件: CSF2RA CSF2RA 💬5. Mavrilimumab 150 mg
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ... | 1件: 46 46 💬5. Mavrilimumab 150 mg
| ||||||||||||||
| 6 | Mavrilimumab 30 mg | 1件: Mavrilimumab Mavrilimumab (Mavrilimumab) | 1件: Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬6. Mavrilimumab 30 mg
| 1件: CSF2RA CSF2RA 💬6. Mavrilimumab 30 mg
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ... | 1件: 46 46 💬6. Mavrilimumab 30 mg
| ||||||||||||||
| 7 | Mavrilimumab 50 mg | 1件: Mavrilimumab Mavrilimumab (Mavrilimumab) | 1件: Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬7. Mavrilimumab 50 mg
| 1件: CSF2RA CSF2RA 💬7. Mavrilimumab 50 mg
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, ... | 1件: 46 46 💬7. Mavrilimumab 50 mg
|